Siga Technologies (SIGA) Asset Writedowns and Impairment (2013 - 2022)
Siga Technologies (SIGA) posted Asset Writedowns and Impairment of $200000.0 for Q1 2022, down 81.96% on a QoQ basis from $1.1 million in Q1 2017.
Siga Technologies (SIGA) Asset Writedowns and Impairment (2013 - 2022) Analysis & Trends
Siga Technologies' Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at $200000.0 for Q1 2022.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $200000.0 in Q1 2022, while the trailing twelve-month figure through Sep 2025 was $200000.0 (changed N/A YoY) and the FY2021 annual result came in at $900000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment was $200000.0 for Q1 2022 at Siga Technologies, down from $1.1 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $200000.0 in Q1 2022 and bottomed at $200000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Siga Technologies | 223.05 Mn | 68.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 200,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Mar 31, 2017 | 1.11 Mn |
| Mar 31, 2017 | 1.11 Mn |
| Mar 31, 2015 | 10,052.00 |
| Mar 31, 2015 | 10,052.00 |
| Dec 31, 2014 | 5,863.00 |
| Dec 31, 2014 | 5,863.00 |
| Sep 30, 2014 | 7,162.00 |
| Sep 30, 2014 | 7,162.00 |
| Jun 30, 2014 | 8,444.00 |
| Jun 30, 2014 | 8,444.00 |
| Mar 31, 2014 | 9,706.00 |
| Mar 31, 2014 | 9,706.00 |
| Dec 31, 2013 | 10,950.00 |
| Dec 31, 2013 | 10,950.00 |